Sennosides 7.5mg tablets
Available from a pharmacy with pharmacist advice
Sennosides (also known as senna glycoside or senna) is a medication used to treat constipation[FDA Label][L771] and empty the large intestine before surgery.
Safety information for pregnancy and breastfeeding
Pregnancy
Breastfeeding
Always consult your doctor or midwife before taking any medicine during pregnancy or while breastfeeding. Source: DrugBank (CC BY-NC 4.0).
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
5 branded products available
Part of the Senease brand family (generic: Sennosides)
MHRA licensed products
View all licensed products for Sennosides on the MHRA register
Cenlax 7.5mg tablets 12 Years Plus
Senease Eighteen Years Plus 7.5mg tablets
Senease Twelve Years Plus 7.5mg tablets
Sennosides 7.5mg tablets 12 Years Plus
Sennosides 7.5mg tablets 12 Years Plus
Therapeutically similar medicines
Similarity based on WHO Anatomical Therapeutic Chemical (ATC) classification and NHS BNF section grouping. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Clinical guidelines and formulary information
British National Formulary
Sennosides
Source: British National Formulary, NICE. Joint Formulary Committee. Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & product information
Official product databases and supply status monitoring
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. emc (electronic medicines compendium) is operated by Datapharm Ltd. Shortage information sourced from NHS Specialist Pharmacy Service (SPS), sps.nhs.uk.
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF codes from NHS Business Services Authority (NHSBSA). ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
0.651h
Mechanism
Sennoside A and B, the components of senna, are metabolized by gut bacteria into…
Food interactions
1 warning
Human targets
1 target
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Absorption
10%
[L771]
Half-life
0.651h
[A176990]
Protein binding
[A19235]
Volume of distribution
0.124L/kg
[A176990]
Metabolism
2.6%
[A19239]…
Elimination
3-6%
[L771]…
Clearance
0.007L/h
[A176990]
Pharmacokinetic data: DrugBank · CC BY-NC 4.0
[L771]
Known interactions with other medications. Always consult a healthcare professional.
Showing 50 of 396 interactions
[A19236]
This is normally reversed after 18 hours however chronic use has been shown to be associated with p53 resistance and potential carcinogenicity leading to colon cancer.
[A19236]
The LD50 value in rats was 5000mg/kg. Subacute studies in rats receiving 20mg/kg and dogs receiving 500mg/kg did not produce signs of toxicity.
[A19238]
Tests for mutagenicity and reproductive toxicity do not indicate toxic effects.
[A19238]
Sennosides are not recommended for use in pregnancy due to genotoxic risks associated with chemically similar compounds.
[L771]
The active metabolite of sennosides is excreted in breast milk, though there are no reports of the laxitive effect in breast fed babies.
[L771]
There is no data on the effects of sennosides on fertility.
[L771]
How the body processes this drug — absorption, distribution, metabolism, and elimination
[L771]
[A176990]
[A19235]
[A176990]
[A19239]
Sennidins A and B are further metabolized to rheinanthrone DB13175 by gut bacteria using beta-glucosidase.
[A19235]
Rheinanthrone DB13175 is absorbed into systemic circulation where 2.6% is metabolized to rhein DB13174 and sennidins A and B via oxidation.
[A19237][A19248][A19235]
Rheinanthrone DB13175 is the major active metabolite of sennosides A and B which produces the laxative effect of the medication.
[A19235]
Rhein DB13174 is also an active metabolite known to have many protective effects.
[A19247]
[L771]
[A176990]
Proteins and enzymes this drug interacts with in the body
PMID:12239222 PMID:30420639
Could also be permeable to urea (By similarity). Also participates in cell permeability to H2O2 and H2O2-mediated signaling .
PMID:20724658
In skin, transports glycerol to the epidermis and stratum corneum, where it maintains hydration, elasticity, and supports lipid biosynthesis for barrier repair (By similarity). In kidney, contributes to the reabsorption of water, helping the body maintain proper fluid balance (By similarity)
ATC A06AB56
ATC A06AB06
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Sennosides
Additional database identifiers
Drugs Product Database (DPD)
5190
Drugs Product Database (DPD)
8798
ChemSpider
5010
BindingDB
92481
HUGO Gene Nomenclature Committee (HGNC)
HGNC:636
GeneCards
AQP3
Guide to Pharmacology
690
UniProt Accession
AQP3_HUMAN
GenBank Gene Database
U28646
GenBank Protein Database
896047
UniProt Accession
Q72547_HV1
DrugBank citations
If you use DrugBank data in your research, please cite the following publications: